IL-12 conditioning improves retrovirally mediated transduction efficiency of CD8+ T cells

被引:0
|
作者
K Andrijauskaite
S Suriano
C A Cloud
M Li
P Kesarwani
L S Stefanik
K M Moxley
M L Salem
E Garrett-Mayer
C M Paulos
S Mehrotra
J N Kochenderfer
D J Cole
M P Rubinstein
机构
[1] Medical University of South Carolina,Department of Surgery
[2] Medical University of South Carolina,Department of Microbiology and Immunology
[3] Loyola University Chicago,Immunology and Biotechnology Division
[4] Faculty of Science,Department of Public Health Sciences
[5] Tanta University,undefined
[6] Medical University of South Carolina,undefined
[7] Experimental Transplantation and Immunology Branch ,undefined
[8] National Cancer Institute,undefined
[9] National Institutes of Health,undefined
来源
Cancer Gene Therapy | 2015年 / 22卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
The ability to genetically modify T cells is a critical component to many immunotherapeutic strategies and research studies. However, the success of these approaches is often limited by transduction efficiency. As retroviral vectors require cell division for integration, transduction efficiency is dependent on the appropriate activation and culture conditions for T cells. Naive CD8+ T cells, which are quiescent, must be first activated to induce cell division to allow genetic modification. To optimize this process, we activated mouse T cells with a panel of different cytokines, including interleukin-2 (IL-2), IL-4, IL-6, IL-7, IL-12, IL-15 and IL-23, known to act on T cells. After activation, cytokines were removed, and activated T cells were retrovirally transduced. We found that IL-12 preconditioning of mouse T cells greatly enhanced transduction efficiency, while preserving function and expansion potential. We also observed a similar transduction-enhancing effect of IL-12 preconditioning on human T cells. These findings provide a simple method to improve the transduction efficiencies of CD8+ T cells.
引用
收藏
页码:360 / 367
页数:7
相关论文
共 50 条
  • [21] IL-12 is required for differentiation of pathogenic CD8+ T cell effectors that cause myocarditis
    Grabie, N
    Delfs, MW
    Westrich, JR
    Love, VA
    Stavrakis, G
    Ahmad, F
    Seidman, CE
    Seidman, JG
    Lichtman, AH
    JOURNAL OF CLINICAL INVESTIGATION, 2003, 111 (05): : 671 - 680
  • [22] The synergy between IL-12 priming of CD8 T cells and lymphodepletion is mediated by host IL-7.
    Johnson, Christopher Bryce
    May, Bennett R.
    Cloud, Colleen A.
    Rubinstein, Mark P.
    Cole, David J.
    CANCER RESEARCH, 2013, 73
  • [23] IL-18, but not IL-12, is required for optimal cytokine production by influenza virus-specific CD8+ T cells
    Denton, Alice E.
    Doherty, Peter C.
    Turner, Stephen J.
    La Gruta, Nicole L.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2007, 37 (02) : 368 - 375
  • [24] IL-12 in conjunction with dendritic cells enhances antiviral CD8+ CTL responses in vitro
    Bhardwaj, N
    Seder, RA
    Reddy, A
    Feldman, MV
    JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (03): : 715 - 722
  • [25] Interleukin 12 (IL-12) is increased in tumour bearing human liver and expands CD8+ and CD56+ T cells in vitro but not in vivo
    Kelly, AM
    Golden-Mason, L
    McEntee, G
    Traynor, O
    Doherty, DG
    Hegarty, JE
    O'Farrelly, C
    CYTOKINE, 2004, 25 (06) : 273 - 282
  • [26] IL-12 Signaling Contributes to the Reprogramming of Neonatal CD8+T Cells
    Gutierrez-Reyna, Darely Y.
    Cedillo-Banos, Alejandra
    Kempis-Calanis, Linda A.
    Ramirez-Pliego, Oscar
    Bargier, Lisa
    Puthier, Denis
    Abad-Flores, Jose D.
    Thomas-Chollier, Morgane
    Thieffry, Denis
    Medina-Rivera, Alejandra
    Spicuglia, Salvatore
    Santana, Maria A.
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [27] CD4 T cell-dependent conditioning of dendritic cells to produce IL-12 results in CD8-mediated graft rejection and avoidance of tolerance
    Filatenkov, AA
    Jacovetty, EL
    Fischer, UB
    Curtsinger, JM
    Mescher, MF
    Ingulli, E
    JOURNAL OF IMMUNOLOGY, 2005, 174 (11): : 6909 - 6917
  • [28] IL-12 AND IL-27 UPREGULATE CD39 EXPRESSION ON CD8+ T-CELLS AND DIFFERENTIALLY AFFECT CD39+CD8+ T-CELL EFFECTOR FUNCTION
    Gerhardt, Lara
    Figueredo, Rene
    Maleki, Saman
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A1070 - A1070
  • [29] Adjuvant effect of IL-12:: Conversion of peptide antigen administration from tolerizing to immunizing for CD8+ T cells in vivo
    Schmidt, CS
    Mescher, MF
    JOURNAL OF IMMUNOLOGY, 1999, 163 (05): : 2561 - 2567
  • [30] IL-12 selectively programs effector pathways that are stably expressed in human CD8+ effector memory T cells in vivo
    Chowdhury, Fatema Z.
    Ramos, Hilario J.
    Davis, Laurie S.
    Forman, James
    Farrar, J. David
    BLOOD, 2011, 118 (14) : 3890 - 3900